**Core Concept**
The question is testing knowledge of the pharmacological management of a sexually transmitted infection, specifically Chlamydia trachomatis. The correct answer requires understanding of the recommended treatment regimen for this bacterium.

**Why the Correct Answer is Right**
Azithromycin is the drug of choice for Chlamydia trachomatis due to its efficacy, safety profile, and convenience of administration. It is a macrolide antibiotic that inhibits protein synthesis in bacteria by binding to the 50S ribosomal subunit. This mechanism of action results in the bacterium's inability to synthesize essential proteins, ultimately leading to its death. Azithromycin is particularly effective against Chlamydia trachomatis because it achieves high concentrations in the cervicovaginal mucosa, the site of infection.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it is not the recommended treatment for Chlamydia trachomatis.
* **Option B:** This option is incorrect because it is not a commonly used antibiotic for treating Chlamydia trachomatis.
* **Option C:** This option is incorrect because it is not the preferred treatment regimen for this bacterium.

**Clinical Pearl / High-Yield Fact**
It is essential to note that a single dose of azithromycin (1 g orally) is recommended as the preferred treatment regimen for uncomplicated Chlamydia trachomatis infection.

**Correct Answer: D. Azithromycin**